Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy
{{output}}
Introduction: Desvenlafaxine, the active metabolite of venlafaxine, is a serotonin norepinephrine reuptake inhibitor (SNRI) recently approved for the treatment of major depressive disorder. It is one of only three medications in ... ...
